Ben van der Schaaf
Partner
Life Sciences expert working with biopharmaceutical companies to solve their biggest challenges pragmatically
![](/sites/default/files/styles/management_team_person_image_m/public/team_management/Ben-van-der-Schaaf_0.jpg,qitok=lRzirwwp.pagespeed.ce.KMCFzWW8q1.jpg)
Areas of Focus
Education
Past Experience
![](/sites/default/files/styles/management_team_person_image_m/public/team_management/Ben-van-der-Schaaf_0.jpg,qitok=lRzirwwp.pagespeed.ce.KMCFzWW8q1.jpg)
Ben is a Life Sciences partner based in Arthur D. Little’s New York office. He is a pharmaceutical expert who works closely with companies to help solve urgent operational issues; designs and implements transformation programs and has extensive experience supporting transactions – both divestment and integration, especially from the operational side.
He is an experienced management consultant and program manager with an international background in finance and general management with 30+ years total experience of which the last 15 have been in the pharmaceutical industry.
Select project experiences include post-merger integration, complex program design and delivery, quality & compliance related programs, strategic sourcing & partnering, organizational analysis and design, commercialization, sales-force effectiveness and operations management. In addition, Ben is skilled in stakeholder management, change management and collaboration, and has broad international business experience. He operates and communicates comfortably across cultures, levels and functions.
Ben holds an MBA with an operations and finance concentration, and an undergraduate degree in accounting and auditing. He is fluent in Dutch and English.
![Why patient centricity is key to long-term pharma company success](/sites/default/files/styles/management_insights_m/public/prism/ADL_Patient_header_image_1605x662.jpg?itok=s8NbdAeS)
Why patient centricity is key to long-term pharma company success
![From good to great: Enhancing innovation performance through effective management processes](/sites/default/files/styles/management_insights_m/public/reports/ADL_TIM_Innovex_From_good_to_great_header_image_1605x662.jpg,qitok=Lic3ni2J.pagespeed.ce.lALy3stwpR.jpg)
From good to great: Enhancing innovation performance through effective management processes
![](/sites/default/files/styles/management_insights_m/public/viewpoints/ADL_the_pandemic_stress_test_web_wide_1.jpg,qitok=Qu5LT71K.pagespeed.ce.Uggc1sJ3GQ.jpg)
The pandemic stress test
![](/sites/default/files/styles/management_insights_m/public/prism/Front,P20cover,P20photo,P20copy.jpg,qitok=9vhdN6DJ.pagespeed.ce.BNwPByKjkX.jpg)
The ecosystem future
![](/sites/default/files/styles/management_insights_m/public/prism/Science%20R.jpg?itok=Z13v-SyO)
Hyper-collaboration in the healthcare and life science industry – The new imperative
![](/sites/default/files/styles/management_insights_m/public/prism/pharma_image.jpg?itok=NjHtuu41)
Pharma: Strategic realignment for a better future
![](/sites/default/files/styles/management_team_person_image_m/public/team_management/Ben-van-der-Schaaf_0.jpg,qitok=lRzirwwp.pagespeed.ce.KMCFzWW8q1.jpg)
Ben is a Life Sciences partner based in Arthur D. Little’s New York office. He is a pharmaceutical expert who works closely with companies to help solve urgent operational issues; designs and implements transformation programs and has extensive experience supporting transactions – both divestment and integration, especially from the operational side.
He is an experienced management consultant and program manager with an international background in finance and general management with 30+ years total experience of which the last 15 have been in the pharmaceutical industry.
Select project experiences include post-merger integration, complex program design and delivery, quality & compliance related programs, strategic sourcing & partnering, organizational analysis and design, commercialization, sales-force effectiveness and operations management. In addition, Ben is skilled in stakeholder management, change management and collaboration, and has broad international business experience. He operates and communicates comfortably across cultures, levels and functions.
Ben holds an MBA with an operations and finance concentration, and an undergraduate degree in accounting and auditing. He is fluent in Dutch and English.
![Why patient centricity is key to long-term pharma company success](/sites/default/files/styles/management_insights_m/public/prism/ADL_Patient_header_image_1605x662.jpg?itok=s8NbdAeS)
Why patient centricity is key to long-term pharma company success
![From good to great: Enhancing innovation performance through effective management processes](/sites/default/files/styles/management_insights_m/public/reports/ADL_TIM_Innovex_From_good_to_great_header_image_1605x662.jpg,qitok=Lic3ni2J.pagespeed.ce.lALy3stwpR.jpg)
From good to great: Enhancing innovation performance through effective management processes
![](/sites/default/files/styles/management_insights_m/public/viewpoints/ADL_the_pandemic_stress_test_web_wide_1.jpg,qitok=Qu5LT71K.pagespeed.ce.Uggc1sJ3GQ.jpg)
The pandemic stress test
![](/sites/default/files/styles/management_insights_m/public/prism/Front,P20cover,P20photo,P20copy.jpg,qitok=9vhdN6DJ.pagespeed.ce.BNwPByKjkX.jpg)
The ecosystem future
![](/sites/default/files/styles/management_insights_m/public/prism/Science%20R.jpg?itok=Z13v-SyO)
Hyper-collaboration in the healthcare and life science industry – The new imperative
![](/sites/default/files/styles/management_insights_m/public/prism/pharma_image.jpg?itok=NjHtuu41)
Pharma: Strategic realignment for a better future
More About Ben
- Henley Management CollegeBusiness Design; Business & Enterprise Architecture
- University of Maine - School of BusinessMaster of Business Administration
- NIVRA-NyenrodeNACII, Accountancy
- PA Consulting GroupManagement Consultant
- The Tussauds GroupDirector of Finance
- Ernst & YoungAuditor